Overview of the hottest pharmaceutical packaging m

Overview of the development of the British pharmaceutical packaging market

in 2001, MSI made a statistical survey of the British pharmaceutical packaging industry from 1997 to 2001 and predicted the period from 2001 to 2006. The survey showed that the development speed of the British pharmaceutical packaging industry was amazing. From 1997 to 2001, it increased by 41%, with an average annual growth rate of 8.9%. By the end of 2001, the total domestic pharmaceutical packaging value was nearly 400million pounds. The industry with the largest proportion is carton packaging, accounting for 28% of the total pharmaceutical packaging, more than £ 100million. Packaging containers ranked second, accounting for 20%

· the proportion of R & D investment in the pharmaceutical industry in the industry ranks first in the world

· the pharmaceutical packaging industry is developing rapidly

· pay attention to the recycling of pharmaceutical packaging waste

· pay attention to the management and market promotion of pharmaceutical packaging enterprises

1 the British pharmaceutical industry is strong, and the proportion of R & D investment to output ranks first in the world

due to the UK's customary spirit of innovation and the strong support of the government, So that it has been in the leading position in the world in new science and new product development. Especially in the pharmaceutical industry where Rd plays a decisive role. Among the most widely used antibiotics in the world, five out of every ten are the results of British pharmaceutical research. The Cambridge Molecular Biology Laboratory has won more Nobel prizes than any other laboratory in the world. The UK is one of the first countries to explore connecting academia and industry into mutually beneficial partners. Biotechnology is the fastest growing field. Britain is creating many technologies to cultivate transgenic plant varieties with disease, insect and herbicide resistance. These technologies are also being used to cultivate plants that can produce new disease resistant vaccines on a large scale, and to develop new, improved and biodegradable industrial materials

over the years, the pharmaceutical industry in Britain has always been in the forefront of the world. In 2000, Glaxo Williams and SmithKline billings, the two giants of the British pharmaceutical industry, announced their merger to become the world's largest pharmaceutical group, with a market value of 114 billion pounds (about 184.2 billion dollars). The group after cooperation is called GlaxoSmithKline, which will control about 7.5% of the global pharmaceutical market

pharmaceutical industry, as the most successful industry in Britain, ranks first in the high-tech industry. There are more than 400 production and research companies in the UK, mainly in the southeast and northwest of the UK. There are more than 60000 employees, one third of whom are scientific researchers. In 2001, the investment in scientific research and development (RD) exceeded 3billion pounds, accounting for more than 37% of the scientific research investment of the entire manufacturing industry in the UK

in addition, the British biotechnology industry is also quite strong, ranking first in Europe and second in the world (second only to the United States). Application fields include medicine, diagnosis, chemical industry, commodities, pesticides, environment, etc. The UK market for biotechnology based products and services is more than £ 15billion. There are 250 biotechnology professional companies in the UK, and more than 400 companies are engaged in related industries. At present, more than 1billion pounds are invested in biotechnology research and development every year. One third of European Biological companies are located in the UK. Laws, patents, consulting, management, scientific research and testing and other professional and supporting services are complete, with tacit cooperation

the investment of UK Rd will promote the R & D level of the whole industry. The huge R D investment in pharmaceutical industry is inseparable from its good return. The gross profit margin of the British pharmaceutical industry is higher than 60%, higher than the international average level, and far higher than other industries in the UK, such as chemical, mechanical and electronic industries

the following is the R D input and R D to output ratio of the pharmaceutical industry in the UK from 1972 to 2001 according to the statistics of the British Pharmaceutical Industry Association. It can be seen from the table that the total R D investment in 2001 was more than 3billion pounds, 2.5 times that in 1991 and 73 times that in 1972. Its input-output ratio increased from 7% in 1972 to 24% in 2001. In the same period of 2001, the average number of other developed countries in the world was less than 10%

growth of pharmaceutical R D investment

year pharmaceutical R D investment pharmaceutical R d

(million pounds) investment ratio (%)

1972 42 7

1985 546 14

1990 1140 17

1991 1239 17

1992 1420 17

1993 1707 21

1994 1918 20

1995 1903 19

1996 2078 20

1997 2251 21

1998 2376 23

1999 2785 23

2000 2843 24

2001 3074 24

2 the British pharmaceutical packaging industry is developing rapidly, Great potential

in 2001, MSI made a statistical survey on the British pharmaceutical packaging industry from 1997 to 2001, and predicted the period from 2001 to 2006. The survey shows that the British pharmaceutical packaging industry has developed at an alarming rate. From 1997 to 2001, it increased by 41%, with an average annual growth rate of 8.9%. By the end of 2001, the total domestic pharmaceutical packaging value was nearly 400million pounds. The industry with the largest proportion is carton packaging, accounting for 28% of the total pharmaceutical packaging, more than £ 100million. Packaging containers ranked second, accounting for 20%. During this period, labels and instructions increased by 51%, with an average annual increase of nearly 11%. MSI predicts that the rapid growth will continue to reach 22% between 2002 and 2006. Other pharmaceutical packaging, such as medical equipment, pharmaceutical distribution systems, liquid injections, such as eye drops, exchange hydraulic systems, are related to many factors, and the effectiveness of ear, nose and some topical drugs are expected to increase by 29%. Carton packaging growth can also reach 29%. MSI believes that the main factors affecting the future growth of pharmaceutical packaging in the UK are as follows:

a new material classification system has been initially established, and the population growth trend has achieved multi variety production; Government policies and regulations; Prescription charges; UK pharmaceutical market conditions; Coordination between packaging and pharmacy

its development status is shown in the figure:

British pharmaceutical packaging market unit: million pounds

1997 290 pounds

1998 310 pounds

1999 330 pounds

2000 380 pounds

2001 400 pounds

* 2002 420 pounds

* 2003 450 pounds

* 2004 470 pounds

* 2005 590 pounds

* 2006 500 pounds

note: * based on 2001 data

source: Trade and SMI assessment and forecast

3 Britain attaches great importance to the recycling of pharmaceutical packaging waste

the British pharmaceutical packaging industry has legislated for the recycling of packaging since 1997. The law stipulates that raw material producers, processors, packaging factories and retailers must perform the obligation of collecting and recycling packaging waste. As far as the whole packaging industry is concerned, the average overall recovery rate of packaging materials in the UK was 42% before the end of 2000, which is far from 50% - 65% of the "2001 standard" formulated by the European Union. However, by the end of 2002, with the active encouragement and supervision of the UK environmental protection department, the recovery rate had reached 61%. Very close to the upper limit of EU standards. It can be seen from the table that British standards are generally higher than the requirements of the European Union

the recycling level of packaging waste in the UK in 2000 and the EU target

the UK reached the EU target in 2001 and the EU target in 2006

comprehensive recycling 42% (61% in 2001) %%

comprehensive regeneration 36%%%

paper 49% 15% 55%

glass 33% 15% 60%

metal 30% 15% 50%

Plastic 12% 15% 20%

source: UK Defra

4 strengthen the management and market promotion of the pharmaceutical processing and packaging machinery manufacturing industry

the British government attaches great importance to strengthening the management and market promotion of packaging enterprises. As the only industry association of processing and packaging machinery in the UK, ppma continues to strengthen all necessary training for its member companies, supervise the implementation of CE standards, and deal with complaints from end users. With the support of the British government, ppma set up its only foreign representative office in China in 1999 to help British manufacturers enter the Chinese market. Since its establishment, the China Representative Office has actively helped British enterprises come to China to participate in exhibitions, visit, find customers and agents, and conduct technical exchanges

in order to better strengthen the development and promotion of pharmaceutical processing and packaging equipment in the UK, following the establishment of the food machinery branch, the British processing and Packaging Machinery Association (ppma) established a pharmaceutical machinery branch with 28 member companies in early 2002. The Management Committee of the branch has been established and put into work

the new branch will provide more specific and targeted services for its member enterprises to better promote the development of enterprises. Ppma currently has 350 member companies. Among them, the manufacturers related to pharmaceutical processing and packaging machinery account for about one third. Among the 28 members of the pharmaceutical machinery branch, there are 22 complete production lines. Most manufacturers of pharmaceutical processing and packaging machinery in the UK are small and medium-sized enterprises, but the performance and quality of their equipment can be rated as world-class. Many companies have hundreds of years of professional equipment production experience. For example, I Holland has been specialized in the production and research of tablet press molds for decades. Newman labeling company has long produced medical labeling machines. Adelphi, which is made by erdefei and has at least one construction floor, is famous for producing small bottle filling equipment for various daily-use chemical and biomedical industries. In addition, there are manesty company, a manufacturer of tablet pressing and coating equipment well-known in the Chinese pharmaceutical industry, swift packaging, a manufacturer of counting machines, pharmaceutical containers of Giusti company, mixers of Winkworth, film sealing machine of maden Edward, vapor filling machine of KP aerofill, etc